Pharvaris officer may sell 46,400 shares in 2026

An officer of Pharvaris N.V. has filed to potentially sell 46,400 common shares under Rule 144, mainly from option exercise and restricted stock.

Available on EDGAR 09/15/2026 - 06:06 PM EDT Accepted by SEC EDGAR 09/15/2026 - 06:05 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) is named as the issuer in a notice that Stefan Andreas Abele, an officer, may sell up to 46,400 common shares under Rule 144 through Morgan Stanley Smith Barney LLC on or after September 15, 2026 on NASDAQ. The shares include 45,000 shares from a stock option exercise dated September 15, 2026 and a total of 1,400 restricted stock shares from grants dated June 8, 9, 11, 12, 2026 and August 11, 2026.

Key Figures

Common shares to be sold under Rule 144: 46,400 shares Aggregate market value of shares: $1,771,125.04 Shares from stock option exercise: 45,000 shares +2 more

5 metrics

Common shares to be sold under Rule 144 46,400 shares Maximum Pharvaris N.V. common shares indicated for sale

Aggregate market value of shares $1,771,125.04 Value associated with 46,400 common shares

Shares from stock option exercise 45,000 shares Common shares underlying stock option exercise dated September 15, 2026

Restricted stock shares 1,400 shares 274, 418, 548, 18, and 142 shares from grants in June and August 2026

Proposed sale date September 15, 2026 Date associated with the planned sale of 46,400 common shares

Key Terms

Rule 144, Stock Option Exercise, Restricted Stock

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Common | 09/15/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Restricted Stock financial

"Common | 06/11/2026 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Pharvaris N.V. (PHVS)?

It discloses that officer Stefan Andreas Abele may sell up to 46,400 common shares of Pharvaris N.V. under Rule 144 through Morgan Stanley Smith Barney LLC, with sales indicated as of September 15, 2026 on NASDAQ.

How many Pharvaris (PHVS) shares are planned to be sold and of what type?

The filing indicates up to 46,400 common shares, consisting of 45,000 shares from a stock option exercise dated September 15, 2026 and 1,400 restricted stock shares from several grant dates in June and August 2026.

What is the reported aggregate market value of the Pharvaris (PHVS) shares in the Form 144?

The Form 144 lists an aggregate market value of $1,771,125.04 for the 46,400 Pharvaris common shares that may be sold under Rule 144 as of the indicated date of September 15, 2026.

Which broker is named for the potential sale of Pharvaris (PHVS) shares?

The potential sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as listed for the common shares to be sold under Rule 144.

What equity awards underlie the Pharvaris (PHVS) shares to be sold?

The shares include 45,000 common shares from a stock option exercise dated September 15, 2026 and restricted stock grants of 274, 418, 548, 18, and 142 shares from dates in June and August 2026, totaling 1,400 restricted shares.

On which market are the Pharvaris (PHVS) shares indicated to be sold?

The common shares covered by the notice are indicated for potential sale on NASDAQ as of September 15, 2026, with up to 46,400 shares of Pharvaris N.V. common stock listed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002002390
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PHARVARIS N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	31 (0)71 2036 410
Name of Person for Whose Account the Securities are To Be Sold	STEFAN ABELE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	46400	1771125.04	70204506	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2026	Stock Option Exercise	Issuer			45000	09/15/2026	Cash
Common	06/11/2026	Restricted Stock	Issuer			274	06/11/2026	Not Applicable
Common	06/12/2026	Restricted Stock	Issuer			418	06/12/2026	Not Applicable
Common	06/08/2026	Restricted Stock	Issuer			548	06/08/2026	Not Applicable
Common	08/11/2026	Restricted Stock	Issuer			18	08/11/2026	Not Applicable
Common	06/09/2026	Restricted Stock	Issuer			142	06/09/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Stefan Andreas Abele
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)